SCHEMBL9289331

SCHEMBL9289331

C=CCn1c(Cl)cc(=O)[nH]c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
ADORA3 P0DMS8 1/20 0.42
ADORA2B P29275 1/20 0.42
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
KMT2A Q03164 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 2/20 0.36
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
ATM Q13315 1/20 0.35
USP2 O75604 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17467913 0.84 ALDH1A1 (0.40) CYP3A4CYP1A2CYP2D6ALDH1A1HPGD
SCHEMBL3885015 0.79 CYP3A4 (0.54) CYP3A4CYP1A2CYP2D6ADORA3ADORA2B
SCHEMBL12284152 0.79 KMT2A (0.47) CYP3A4CYP1A2CYP2D6ADORA3ADORA2B
SCHEMBL9257137 0.76 KMT2A (0.51) CYP3A4CYP1A2CYP2D6ALDH1A1HPGD
SCHEMBL7964576 0.75 KMT2A (0.53) CYP3A4CYP1A2CYP2D6ADORA3ADORA2B
SCHEMBL17468147 0.73 UNG (0.41) CYP3A4CYP1A2CYP2D6ALDH1A1HPGD
SCHEMBL5742355 0.73 MAPT (0.41) CYP3A4CYP1A2CYP2D6ADORA3ADORA2B
SCHEMBL157928 0.72 CYP3A4 (0.71) CYP3A4CYP1A2CYP2D6ADORA3ADORA2B
SCHEMBL8195993 0.71 ALDH1A1 (0.43) CYP3A4CYP1A2CYP2D6ADORA2BALDH1A1
SCHEMBL5408183 0.71 B3GNT2 (0.42) CYP3A4CYP1A2CYP2D6ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5382585-A Treatment of cardiovascular disorders and erectile dysfunctions CASSELLA AG (DE) 1995-01-17 US disclosed